Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Sep;98(1):259–267. doi: 10.1111/j.1476-5381.1989.tb16890.x

The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.

J R Boot 1, A Bond 1, R Gooderham 1, A O'Brien 1, M Parsons 1, K H Thomas 1
PMCID: PMC1854672  PMID: 2553189

Abstract

1. This paper describes the evaluation of LY170680 (5-less than 3-[2(R) (carboxyethylthio)-(S)-hydroxypentadeca 3(E)5(Z)-dienyl]phenyl greater than 1H tetrazole, as an antagonist of the cysteinyl leukotrienes C4, D4, E4, in a variety of in vitro and in vivo models. 2. In vitro, LY170680 was a potent, selective, and competitive antagonist of LTD4, and LTE4. It produced a concentration-dependent rightward displacement of the concentration-response curves elicited by either LTD4 or LTE4 on both the guinea-pig ileal and tracheal preparation. The pA2 values for LY170680 were estimated to be 8.1 +/- 0.2 (n = 8) and 8.1 +/- 0.1 (n = 6) on trachea, and 8.7 +/- 0.1 (n = 12) and 9.0 +/- 0.3 (n = 6) on ileum for both LTD4 and LTE4 respectively. The slopes of the Schild plots in these studies were all close to unity. 3. LY170680 was shown to be a modest antagonist of the LTC4-induced responses on guinea-pig ileum (pA2 7.0 +/- 0.2 n = 5), but had no discernable effects against contractions induced by histamine, prostaglandin E2 (PGE2), PGF2 alpha or acetylcholine. The compound also reduced the LTC4-induced responses on trachea, but in a non competitive manner. 4. Intravenous LY170680 reduced in a dose-dependent manner (ED50 3.8 mg kg-1, 60 min pretreatment) the fall in compliance in the anaesthetized guinea-pig, and the rise in total pulmonary resistance (TPR) (ED50 2.0 mg kg-1, 30 min pretreatment) in the artificially ventilated guinea-pig, produced by intraveous LTD4.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMDUR M. O., MEAD J. Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol. 1958 Feb;192(2):364–368. doi: 10.1152/ajplegacy.1958.192.2.364. [DOI] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson W. H., O'Donnell M., Simko B. A., Welton A. F. An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in the guinea-pig. Br J Pharmacol. 1983 Jan;78(1):67–74. doi: 10.1111/j.1476-5381.1983.tb09363.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clay T. P., Miller P., Stead H. A lung perfusion technique for the detection of antigenic intrapulmonary bronchoconstriction and its mediation. J Pharmacol Methods. 1985 Nov;14(3):169–179. doi: 10.1016/0160-5402(85)90030-0. [DOI] [PubMed] [Google Scholar]
  5. Fleisch J. H., Rinkema L. E., Haisch K. D., Swanson-Bean D., Goodson T., Ho P. P., Marshall W. S. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther. 1985 Apr;233(1):148–157. [PubMed] [Google Scholar]
  6. Holroyde M. C., Altounyan R. E., Cole M., Dixon M., Elliott E. V. Bronchoconstriction produced in man by leukotrienes C and D. Lancet. 1981 Jul 4;2(8236):17–18. doi: 10.1016/s0140-6736(81)90254-3. [DOI] [PubMed] [Google Scholar]
  7. Ibe B. O., Campbell W. B. Synthesis and metabolism of leukotrienes by human endothelial cells: influence on prostacyclin release. Biochim Biophys Acta. 1988 Jun 15;960(3):309–321. doi: 10.1016/0005-2760(88)90039-2. [DOI] [PubMed] [Google Scholar]
  8. Leitch A. G., Austen K. F., Corey E. J., Drazen J. M. Effects of indomethacin on the guinea-pig pulmonary response to intravenous leukotrienes C4 and D4. Clin Sci (Lond) 1983 Sep;65(3):281–287. doi: 10.1042/cs0650281. [DOI] [PubMed] [Google Scholar]
  9. Lewis R. A., Drazen J. M., Figueiredo J. C., Corey E. J., Austen K. F. A review of recent contributions on biologically active products of arachidonate conversion. Int J Immunopharmacol. 1982;4(2):85–90. doi: 10.1016/0192-0561(82)90055-8. [DOI] [PubMed] [Google Scholar]
  10. Marom Z., Shelhamer J. H., Bach M. K., Morton D. R., Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis. 1982 Sep;126(3):449–451. doi: 10.1164/arrd.1982.126.3.449. [DOI] [PubMed] [Google Scholar]
  11. Orehek J., Douglas J. S., Lewis A. J., Bouhuys A. Prostaglandin regulation of airway smooth muscle tone. Nat New Biol. 1973 Sep 19;245(142):84–85. doi: 10.1038/newbio245084a0. [DOI] [PubMed] [Google Scholar]
  12. Payne A. N., de Nucci G. Anaphylaxis in guinea pigs induced by ovalbumin aerosol in vivo and in vitro methods. J Pharmacol Methods. 1987 Mar;17(1):83–90. doi: 10.1016/0160-5402(87)90040-4. [DOI] [PubMed] [Google Scholar]
  13. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  14. Stengel P. W., Pechous P. A., Silbaugh S. A. Mechanism of A23187-induced airway obstruction in the guinea pig. Prostaglandins. 1987 Apr;33(4):567–577. doi: 10.1016/0090-6980(87)90280-2. [DOI] [PubMed] [Google Scholar]
  15. Weichman B. M., Muccitelli R. M., Osborn R. R., Holden D. A., Gleason J. G., Wasserman M. A. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Ther. 1982 Jul;222(1):202–208. [PubMed] [Google Scholar]
  16. Weiss J. W., Drazen J. M., Coles N., McFadden E. R., Jr, Weller P. F., Corey E. J., Lewis R. A., Austen K. F. Bronchoconstrictor effects of leukotriene C in humans. Science. 1982 Apr 9;216(4542):196–198. doi: 10.1126/science.7063880. [DOI] [PubMed] [Google Scholar]
  17. Woodward D. F., Weichman B. M., Gill C. A., Wasserman M. A. The effect of synthetic leukotrienes on tracheal microvascular permeability. Prostaglandins. 1983 Jan;25(1):131–142. doi: 10.1016/0090-6980(83)90142-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES